MAPK pathways involving extracellular signaling-regulated kinases (ERKs), the Jun N-terminal kinases (JNK) and p38 MAPK are signal transduction pathways important for modulating drug sensitivity and resistance in cancers [74]. This evidence concerns the gene MAPK8 and cancer.